Although SLC11A1 shows excellent immunological prognostic value in other cancers, our K-M curves show better survival for high-expression groups of GBP2, P2RX7, and HCLS1 but not SLC11A1 in EC. This evidence concerns the gene SLC11A1 and cancer.